Rheumatology News

 
  • Alert Self-injectable Belimumab for SLE Approved in Europe With training, patients with SLE can administer the new subcutaneous formulation as a once-weekly injection from a single-dose prefilled syringe or from a single-dose autoinjector.
  • Alert FDA OKs Therapy for Rare Genetic Enzyme Disorder Vestronidase alfa-vjbk (Mepsevii) is the first FDA-approved treatment for children and adults with mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome.
 

Today on Medscape

Top Stories from Across Medicine

Top Medical News from Across Medscape

  • Brain Imaging Identifies CTE in a Living PersonA PET scan using a tau tracer accurately diagnosed chronic traumatic encephalopathy in a living professional football player, a finding researchers describe as a diagnostic 'milestone.'
  • Thrombectomy Up to 24 Hours Effective in Certain StrokesPublished results of the DAWN trial show patients with salvageable brain tissue identified by 'clinical-core mismatch' benefitted from endovascular therapy up to 24 hours after onset.
  • Whistleblowing Neurosurgeon Wins Big, but at a PriceA neurosurgeon convinced a judge that he was fired for reporting a colleague whose license was later suspended for disruptive behavior. The victor's $17.5 million court award, though, comes at a price.

Perspective

Business of Medicine

Columnists

Advisory Board

 

Site Editorial Director

Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape
метан таблетки

look

еще по теме